Clinical Trial Update: Combination Chemotherapy With or Without Celecoxib in Treating Patients With Metastatic Colorectal Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing combination chemotherapy with or without celecoxib in metastatic colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Celecoxib (Celecoxib)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Colorectal Cancer | Phase 3 | Status: COMPLETED